Metabolic carbohydrate cell wall probes for bacterial structure and immune recognition studies
用于细菌结构和免疫识别研究的代谢碳水化合物细胞壁探针
基本信息
- 批准号:9750646
- 负责人:
- 金额:$ 33.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-11 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAlkynesAmino SugarsAnabolismAntibiotic TherapyAntibiotic susceptibilityAntibioticsArchitectureAzidesBacillus subtilisBacteriaBindingBiologicalCarbohydratesCell ShapeCell WallCellsCellular biologyChargeChemistryComplementDataDisciplineDiseaseDoseElementsEngineeringEnzymesEscherichia coliG CellsGenerationsGenetic EngineeringGenomeGlucosamineGoalsGrantGrowthHealthHelicobacter pyloriHeterogeneityHumanHuman bodyImmuneImmune responseImmunologistInflammatoryLabelLactobacillusLightLinkMedicalMetabolicMethodologyMethodsMicrobeMuramic AcidMycobacterium tuberculosisNatural ImmunityNatureOrganismOsmotic PressurePathogenesisPathway interactionsPeptidesPeptidoglycanPermeabilityPhosphotransferasesPolymersPolysaccharidesProblem SolvingProductionPropertyProteinsRecyclingReporterResearch PersonnelShapesStomachStructureSubstrate SpecificityTechniquesTransferaseUnited States National Institutes of HealthUridine Diphosphate SugarsVertebral columnbiochemical toolsbody sensecarbohydrate structurechemical synthesiscommensal bacteriacommensal microbescrosslinkdesigndrug developmenteffective therapyimmune activationinnovationlarge scale productionmycobacterialnoveloff-label usepathogenpathogenic bacteriapathogenic microbepressuresmall moleculesugartooluptake
项目摘要
PROJECT SUMMARY
Bacterial cells surround themselves with a peptidoglycan (PG) cell wall, an essential structure that resists
changes in osmotic pressure and other environmental insults. To a certain degree, PG is also essential to
humans as antibiotics target its destruction and fragments activate immune responses. The basic building
blocks of PG have been known for over fifty years; however, the higher architectural features of this polymer
and complete set of immunostimulating fragments remain unknown. We hypothesize that differences in overall
PG structure and fragment generation are important for sensing pathogenic bacteria. The glycan of the PG is
essential for immune recognition; study of this important structure has been hampered by a lack of tools to
label and track the fate of PG carbohydrate precursors and the resultant polymer in living cells. Currently,
researchers are limited to few carbohydrate probes and even fewer larger fragments. Chemical synthesis is
laborious and challenging to even expert carbohydrate chemists. The goal of this U01 proposal is to develop a
method to label the glycan of the PG in a range of microbes to facilitate identification, tracking, manipulation
and analysis of the glycans derived from PG with their biological binding partners and determine their functions.
We propose to utilize a metabolic labeling approach in which the necessary functionalized PG biosynthetic
building blocks are synthesized, provided to the microbe and incorporated in the backbone of the polymer. This
has not been done before as the synthesis of the UDP-sugar building blocks is challenging and the uptake and
processing pathways for the free sugars are not widely distributed. To overcome this challenge we propose
parallel approaches which utilize either chemoenzymatic synthesis or genetic engineering. The bacterial PG
recycling enzymes, AmgK and MurU have relaxed substrate specificity for N-acetyl-muramic acid lactols,
allowing the production of labeled UDP-PG precursors. In Aim One, a large-scale chemoenzymatic synthesis
of a variety of UDP-PG derivatives will be optimized and these molecules will be provided to a variety of
pathogenic and commensal microbes for subsequent PG incorporation. Kits will be developed to distribute
these essential carbohydrates. For Aim Two tagged lactol substrates will be provided to cells whose genomes
have been engineered to encode for AmgK and MurU. As Escherichia coli and Bacillus subtilis are amendable
to this approach, this methodology will be extended to pathogens such as Helicobacter pylori (Hp) and
Mycobacterium tuberculosis (Mtb) as well as commensal bacteria. Aim Three will showcase the utility of this
method for immunologists and microbiologists: (1) glycan-containing immunostimulatory molecules from Mtb,
and Hp will be tracked, sorted and identified; (2) Hp and Mtb's PG structural features related to pathogenesis
and antibiotic susceptibility will be interrogated. This innovative carbohydrate metabolic labeling method for
peptidoglycan will be an approachable yet powerful technique for biomedical researchers and a valuable
addition to the Glycoscience Consortium.
项目摘要
细菌细胞用肽聚糖(PG)细胞壁包围自己,这是一种抵抗细菌生长的基本结构。
渗透压和其他环境损害的变化。在某种程度上,PG也是必不可少的,
人类作为抗生素的目标,它的破坏和片段激活免疫反应。的基本构建
PG块已经知道了五十多年;然而,这种聚合物的更高结构特征
并且完整的免疫刺激片段集仍然未知。我们假设,
PG结构和片段产生对于传感病原菌是重要的。PG的聚糖是
对于免疫识别至关重要;由于缺乏工具,
标记和跟踪PG碳水化合物前体和活细胞中所得聚合物的命运。目前,
研究人员限于很少的碳水化合物探针和更少的较大片段。化学合成
甚至对专家碳水化合物化学家来说也是费力和具有挑战性的。本U 01提案的目标是开发一个
标记一系列微生物中PG聚糖的方法,以便于识别、跟踪、操作
分析PG衍生的聚糖及其生物结合配偶体,并确定其功能。
我们建议利用代谢标记方法,其中必要的官能化PG生物合成
合成结构单元,提供给微生物并掺入聚合物的主链中。这
以前没有做过,因为UDP-糖结构单元的合成具有挑战性,
游离糖的加工途径分布不广。为了克服这一挑战,我们建议
利用化学酶促合成或基因工程的平行方法。细菌PG
再循环酶,AmgK和MurU对N-乙酰基-胞壁酸乳糖醇具有松弛的底物特异性,
允许产生标记的UDP-PG前体。目标一,大规模化学酶促合成
将优化各种UDP-PG衍生物的分子,并将这些分子提供给各种实验室。
病原微生物和真菌用于随后的PG掺入。将开发工具包,
这些必需的碳水化合物。为了达到目的,将两种标记的乳醇底物提供给基因组
已经被设计成编码AmgK和MurU。由于大肠杆菌和枯草芽孢杆菌是可降解的,
为了这种方法,这种方法将扩展到病原体,如幽门螺杆菌(Hp),
结核分枝杆菌(Mtb)以及细菌。目标三将展示这一工具的实用性
免疫学家和微生物学家的方法:(1)来自Mtb的含聚糖的免疫刺激分子,
(2)Hp和Mtb与致病相关的PG结构特征
和抗生素敏感性进行调查。这种创新的碳水化合物代谢标记方法,
肽聚糖对于生物医学研究人员来说将是一种平易近人但功能强大的技术,也是一种有价值的
加入糖科学联盟。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Leimkuhler Grimes其他文献
PGLYRP1-mediated intracellular peptidoglycan detection promotes intestinal mucosal protection
PGLYRP1 介导的细胞内肽聚糖检测促进肠道黏膜保护
- DOI:
10.1038/s41467-025-57126-9 - 发表时间:
2025-02-21 - 期刊:
- 影响因子:15.700
- 作者:
Shuyuan Chen;Rachel Putnik;Xi Li;Alka Diwaker;Marina Vasconcelos;Shuzhen Liu;Sudershan Gondi;Junhui Zhou;Lei Guo;Lin Xu;Sebastian Temme;Klare Bersch;Stephen Hyland;Jianyi Yin;Ezra Burstein;Brian J. Bahnson;Jeffrey C. Gildersleeve;Catherine Leimkuhler Grimes;Hans-Christian Reinecker - 通讯作者:
Hans-Christian Reinecker
Catherine Leimkuhler Grimes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Leimkuhler Grimes', 18)}}的其他基金
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
- 批准号:
10549646 - 财政年份:2023
- 资助金额:
$ 33.18万 - 项目类别:
Host proteins that interact with the BCG cell envelope
与 BCG 细胞包膜相互作用的宿主蛋白
- 批准号:
10408860 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Host proteins that interact with the BCG cell envelope
与 BCG 细胞包膜相互作用的宿主蛋白
- 批准号:
10288316 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
- 批准号:
10228018 - 财政年份:2020
- 资助金额:
$ 33.18万 - 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
- 批准号:
10402325 - 财政年份:2020
- 资助金额:
$ 33.18万 - 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
- 批准号:
10620744 - 财政年份:2020
- 资助金额:
$ 33.18万 - 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
- 批准号:
10034684 - 财政年份:2020
- 资助金额:
$ 33.18万 - 项目类别:
Development of an Immunostimulatory Small Molecule Library
免疫刺激小分子库的开发
- 批准号:
8916148 - 财政年份:
- 资助金额:
$ 33.18万 - 项目类别:
Development of an Immunostimulatory Small Molecule Library
免疫刺激小分子库的开发
- 批准号:
8653104 - 财政年份:
- 资助金额:
$ 33.18万 - 项目类别:
Development of an Immunostimulatory Small Molecule Library
免疫刺激小分子库的开发
- 批准号:
9302811 - 财政年份:
- 资助金额:
$ 33.18万 - 项目类别:
相似海外基金
Reactions of Alkynes with Metal-Coordinated Phosphenium Ions
炔烃与金属配位磷离子的反应
- 批准号:
573824-2022 - 财政年份:2022
- 资助金额:
$ 33.18万 - 项目类别:
University Undergraduate Student Research Awards
Exploring the missing reactivity of heteroatom-substituted alkynes
探索杂原子取代的炔烃缺失的反应性
- 批准号:
559671-2021 - 财政年份:2022
- 资助金额:
$ 33.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
LEAPS-MPS: Developing a Spectroscopic Map for Terminal Alkynes
LEAPS-MPS:开发末端炔烃的光谱图
- 批准号:
2213339 - 财政年份:2022
- 资助金额:
$ 33.18万 - 项目类别:
Standard Grant
Development of Synthetic Methods for Hetero-fused pi-Conjugated Compounds Based on Trans-Addition to Alkynes
基于炔烃反式加成的异稠合π共轭化合物的合成方法研究进展
- 批准号:
21K05061 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Enantioselective Carboalumination of Alkenes and Alkynes Catalyzed by Rare-Erath Metal Catalysts
稀土金属催化剂催化烯烃和炔烃对映选择性碳铝化反应的研究进展
- 批准号:
21F21334 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
- 批准号:
10544730 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
- 批准号:
10320911 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Development of beta-carbon elimination reactions of alkynes from unstrained vinyl complexes
无应变乙烯基配合物中炔烃的β-碳消除反应的进展
- 批准号:
21K05101 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reactions of Alkynes with Metal-Coordinated Phosphenium Ions
炔烃与金属配位磷离子的反应
- 批准号:
563146-2021 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:
University Undergraduate Student Research Awards
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
- 批准号:
10581995 - 财政年份:2021
- 资助金额:
$ 33.18万 - 项目类别:














{{item.name}}会员




